# Kesimpta Pregnancy and Infant Safety Study Using Real World Data

> **NCT06156683** · — · RECRUITING · sponsor: **Novartis Pharmaceuticals** · enrollment: 1500 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **OTHER:** Multiple sclerosis disease modifying drug

## Key facts

- **NCT ID:** NCT06156683
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-30
- **Primary completion:** 2028-02-01
- **Final completion:** 2028-02-01
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06156683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06156683, "Kesimpta Pregnancy and Infant Safety Study Using Real World Data". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06156683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*